EIS holdings

Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 22.62% at a quoted market price (level 1), 5 issuer countries.

EIS's largest investment is Teva Pharmaceutical Industries Ltd at 8.82% of net assets. Bank Leumi LE Israel BM and Bank Hapoalim BM follow; the three together are 23.97%. Ten companies are 51.76% of the fund; the other 109 share the rest. Among the 721 equity funds measured here, EIS behaves like 27.5 holdings against a median of 42.4 — 1.5 times more concentrated than the median. Across 27 quarterly filings EIS has become less concentrated: it behaved like 21.5 at 2019-11-30 and 27.5 at 2026-05-31. Between the 2026-02-28 and 2026-05-31 filings 9 positions were added and 2 dropped; 9.7% of the weight moved.

Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.

Between 2019-11-30 and 2026-05-31, EIS went from behaving like 21.5 equally weighted positions to 27.5 — 28% more, while its top ten went from 59.54% to 51.76% of net assets. Read across the funds on the concentration-over-time table.

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

EIS's filing lists 120 positions including 2.59% of net assets in securities-lending cash collateral. Counted as filed the fund reads 27.1 effective holdings with a top ten of 51.71%; on its own investments — the figure above — it reads 27.5 with a top ten of 51.76%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.

The 15 largest of 119 positions in EIS's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: EIS.csv.gz.

Share of EIS's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.

Monthly total returns from Item B.5 of EIS's own filings, 81 months on record. Not computed here and not from a price feed.

Cross-checked against a series computed separately from prices: median difference 0.24 percentage points over 81 months, which is roughly the distributions. Every month with the filing it came from: EIS.json · all funds.

The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-05-31, $25m was out to 10 borrowers, 2.47% of net assets. The largest, GOLDMAN SACHS & CO., held 43.7% of it.

Cash collateral reported against the loan: 2.59% of net assets, 104.7% of the amount lent. That is a floor on the collateral, not the whole of it — collateral the fund does not hold as a position is not in this filing, so a figure under 100% is not evidence of under-collateralisation. How that figure behaves across all funds. Every quarter EIS has filed, with each borrower: EIS.json · all funds.

112 positions became 119: 9 added (1.6% of the fund at the later date), 2 dropped (0.0% at the earlier date). Half the sum of all weight changes, a turnover proxy: 9.7%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of EIS compared this way, as a feed: changes.xml · all funds: filings received.

New: CYBERARK SOFTWARE LTD (0.44%), Max Stock Ltd (0.34%), MIVTAH SHAMIR HOLDINGS LTD. (0.20%), Neto Malinda Trading Ltd (0.16%), I.D.I. INSURANCE COMPANY LTD (0.15%), I.B.I INVESTMENT HOUSE LTD (0.15%). Gone: Similarweb Ltd (0.03%), HONG KONG DOLLAR (0.00%).

22.6% of EIS is carried at a quoted market price (fair-value level 1). Categories and levels are the filer's, from Form N-PORT; what a low level-1 share does and does not mean is in the measure's page.

A position count cannot describe a fund that uses derivatives, because a swap is filed at its unrealised gain, not its exposure. These are the notionals the fund itself reported, against net assets of $1.03B. Notional of an interest-rate or currency swap is not equity exposure.

Full detail for every fund that files derivatives: leverage.json (CC BY 4.0).

Every measured equity fund lined up by how many holdings it behaves like; these sit either side of EIS (27.5). Same filings, same arithmetic. Position in this list says nothing about which fund is better.